Skip to main content

Month: May 2021

Cegedim Insurance Solutions et Shift Technology signent un partenariat d’envergure

        COMMUNIQUE DE PRESSECegedim Insurance Solutions et Shift Technology signent un partenariat d’envergure pour accompagner les assureurs dans la lutte contre la fraude en santé et prévoyance Boulogne-Billancourt, France, le 25 mai 2021 Cegedim Insurance Solutions, acteur majeur des solutions logicielles et services pour l’assurance de personnes, et Shift, fournisseur de solutions d’automatisation et d’optimisation des décisions basées sur l’IA pour le secteur de l’assurance, associent leurs expertises pour proposer au marché français de la santé et de la prévoyance des solutions de référence en matière de lutte contre la fraude et le blanchiment des capitaux (LCB-FT). Face à l’évolution des comportements de fraude, Cegedim Insurance Solutions, qui propose déjà une solution dans le domaine optique, a souhaité élargir son...

Continue reading

Share buy-back programme – week 20

Nasdaq CopenhagenLondon Stock ExchangeOther stakeholders Date        25.05.2021 Share buy-back programme – week 20 The share buy-back programme runs from and including 4 February 2021 up to and including 30 July 2021. During this period Ringkjøbing Landbobank will buy-back shares to a maximum market value of DKK 255 million under a share buy-back programme, see company announcement of 3 February 2021. The programme is implemented in compliance with EU Commission Regulation No. 596/2014 of 16 April 2014 and EU Commission Delegated Regulation No. 2016/1052 of 8 March 2016, which together constitute the “Safe Harbour” regulation. The following transactions have been made under the programme:Date Number of shares Average purchase price (DKK) Total purchased under the programme (DKK)Total in accordance with the last announcement227,500606.03137,870,75817...

Continue reading

Scandinavian Tobacco Group A/S: Major Shareholders Announcement

Company Announcement No. 27/2021  Copenhagen, 25 May 2021 Major Shareholder’s Announcement With reference to Section 38 of the Danish Act on Capital Markets (kapitalmarkedsloven)) it is hereby announced that Parvus Asset Management Europe Limited has informed Scandinavian Tobacco Group A/S (the “Company”) that funds administered by companies within Parvus Asset Management Europe Limited on 19 May 2021 control shares in total amounting to more than 10% of the Company’s share capital as the threshold was passively crossed following reduction of the Company’s share capital, and Parvus Asset Management Europe Limited exercises more than 10% of the Company’s voting rights. Funds administered by Parvus Asset Management Europe Limited thus control 9,987,601 shares with a nominal value of DKK 1 (aggregate nominal value DKK 9,987,601), corresponding...

Continue reading

Verona Pharma to Present at Jefferies Virtual Healthcare Conference

LONDON and RALEIGH, N.C., May 25, 2021 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that David Zaccardelli, Chief Executive Officer and President, will present a company overview at the Jefferies Virtual Healthcare Conference on Tuesday, June 1, 2021 at 9:00 AM ET. A webcast of the event will be available for 90 days on the Events and Presentations link on the Investors page of the Company’s website, www.veronapharma.com.   Verona Pharma plc US Tel: +1-833-417-0262UK Tel: +44 (0)203 283 4200Victoria Stewart, Director of Communications info@veronapharma.com   Argot Partners(US Investor Enquiries) Tel: +1-212-600-1902verona@argotpartners.comKimberly Minarovich / Michael Barron     Optimum Strategic...

Continue reading

Tiziana Life Sciences Announces Initiation of Clinical Trial in a Secondary Progressive Multiple Sclerosis (SPMS) Patient with Nasal Administration of Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody, Under an Individual Patient Expanded Access Program

The first patient with SPMS was dosed on May 24, 2021 with nasally administered Foralumab. The treatment regimen will continue for six months to examine long-term safety, tolerability and clinical responses. Previous clinical studies in healthy volunteers and COVID-19 patients showed that nasally administered Foralumab is well-tolerated with no apparent severe adverse events (SAEs) when dosed for up to 10 consecutive days. Results from these studies showed strong anti-inflammatory effects of the treatment regimen.NEW YORK and LONDON, May 25, 2021 (GLOBE NEWSWIRE) — Tiziana Life Sciences plc (NASDAQ: TLSA, LSE: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics for inflammatory diseases and cancers, is pleased to announce that the first patient with secondary progressive multiple sclerosis...

Continue reading

Mkango Releases Financial Statements and Management’s Discussion and Analysis for the Period Ending March 31, 2021

LONDON and VANCOUVER, British Columbia, May 25, 2021 (GLOBE NEWSWIRE) — Mkango Resources Ltd. (AIM/TSX-V: MKA) (the “Company” or “Mkango“) is pleased to announce that it has released the Financial Statements and Management’s Discussion and Analysis for the period ending March 31, 2021. The reports will be available under the Company’s profile on SEDAR (www.sedar.com) and on the Company’s website (https://mkango.ca/investors/financials/).For further information on Mkango, please contact:Mkango Resources Limited     William Dawes Alexander LemonChief Executive Officer Presidentwill@mkango.ca  alex@mkango.ca UK: +44 207 3722 744   Canada: +1 403 444 5979  www.mkango.ca   @MkangoResources     Blytheweigh  Financial Public Relations  Tim Blythe  UK:...

Continue reading

10/2021・Early close of the Offering of new and existing shares in Trifork

Company announcement no. 10 / 2021Schindellegi, Switzerland – 25 May 2021 NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA OR CANADA, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION WHERE THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL This announcement does not constitute an offering memorandum or a prospectus as defined by Regulation (EU) No. 2017/1129 of 14 June 2017. The offer to acquire securities pursuant to any offering will be made, and any investor should make his investment decision, solely on the basis of information that is contained in a prospectus made generally available in Denmark in connection with the offering. Copies of the prospectus may be obtained by persons in Denmark through the website of the Company as set forth elsewhere in this announcement. Early...

Continue reading

BW Offshore: First quarter results 2021

First quarter results 2021 HIGHLIGHTSEBITDA of USD 110.8 million Operating cashflow USD 114 million, excluding final settlement of USD 43 million to Petrobras related to Cidade de Sao Mateus Equity ratio 39.7% and USD 294.4 million in available liquidity Successfully completed Floating Wind subsidiary BW Ideol private placement and listing on Euronext Growth Signed USD 4.6 billion, 15-year firm FPSO Services contract for Barossa FPSO with Santos Firm FPSO contract backlog of USD 7 billion at end of March, up from USD 2.6 billion at year end 2020 Recycling of FPSO Berge Helene in April in compliance with Hong Kong convention Cash dividend of USD 0.035 per share Contemplating inaugural green bond issueIn the first quarter, BW Offshore made significant progress in executing the dual-track strategy of evolving the core FPSO business and...

Continue reading

SeaBird Exploration Plc: Q1 2021 update – Rebranding and reorganizing into Green Energy Group

25 May 2021, Limassol, Cyprus SeaBird Exploration Plc announces its first quarter 2021 update and report. Headlines Q1 2021Rebranding and reorganizing into Green Energy Group (SBX Plc, “The Company”) to be proposed to the upcoming AGM Rebranding marks a change in strategy and commitment to the green energy transition Green Energy Group relocates from Cyprus to Norway Offshore seismic business area maintains SeaBird Exploration name and becomes subsidiary of Green Energy Group Completed listing of Green Minerals AS on Euronext Growth Signed LOI with a consortium led by OSI Industries (UK) Ltd for a HEDSMS First ever contract award in offshore wind Awarded OBN source contract for 90 days in the Eastern Hemisphere EBITDA negative $0.5 million on 33% utilization Market conditions improvingThe company will host a webcast at 08:00 CEST today....

Continue reading

Steve Muehler – Debt Capital Markets – Alternative Aviation Finance

According to Steve Muehler, “The global airline industry was value at $686 billion USD in 2020, and due to the COVID-19 Pandemic, it is projected to only reach $776.86 Billion USD here in 2021, but it is expected to return to its more traditional growth pace in 2022. Currently, the aviation industry supports $3.5 Trillion USD of the world’s gross domestic product, which is if it was a country, it would rank 17th in size by GDP. With the new technologies of this industry, including commercial passenger flight of more than mach 1, this industry is going to grow significantly over the next ten plus years.” “We have partnered with some of the leading investment banks in this industry that are currently deploying both debt and equity capital into the aviation markets, both through public financing transactions and private financing transactions....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.